Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Other | Homo sapiens | Yuxuan Sun | |||||
GSE241934 |
Neoadjuvant sintilimab plus chemotherapy in early-stage EGFR-mutant NSCLC: phase 2 trial interim results (NEOTIDE/CTONG2104)
|
88 | Yuxuan Sun | May 17, 2024 |